Milnacipran

Additional information:
Milnacipran is a serotonin–norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia. It is not approved for the clinical treatment of major depressive disorder in the USA.|Product information|CAS Number: 92623-85-3|Molecular Weight: 246.35|Formula: C15H22N2O|Synonym:|Dalcipran|Ixel|Savella|Toledomin|Chemical Name: (1R, 2S)-2-(aminomethyl)-N, N-diethyl-1-phenylcyclopropane-1-carboxamide, rel-|Smiles: CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C1C=CC=CC=1 |&1:7,9||InChiKey: GJJFMKBJSRMPLA-HIFRSBDPSA-N|InChi: InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m1/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|